孕早期暴露于莫达非尼与先天畸形风险的相关性研究。
First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations.
机构信息
Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
出版信息
JAMA. 2020 Jan 28;323(4):374-376. doi: 10.1001/jama.2019.20008.
Abstract
This study uses pharmacoepidemiology data from Danish national health registries to examine the association between first-trimester exposure to modafinil and risk of major congenital malformations.
摘要
本研究使用丹麦国家健康注册中心的药物流行病学数据，考察了孕早期接触莫达非尼与重大先天性畸形风险之间的关系。
相似文献
1
First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations.孕早期暴露于莫达非尼与先天畸形风险的相关性研究。
JAMA. 2020 Jan 28;323(4):374-376. doi: 10.1001/jama.2019.20008.
2
Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway.瑞典和挪威妊娠早期接触莫达非尼后的畸形发生率。
JAMA. 2020 Sep 1;324(9):895-897. doi: 10.1001/jama.2020.9840.
3
First-trimester exposure to methylphenidate: a population-based cohort study.孕早期暴露于哌醋甲酯：基于人群的队列研究。
J Clin Psychiatry. 2014 Jan;75(1):e88-93. doi: 10.4088/JCP.13m08708.
4
Risk of Major Congenital Malformations Associated With the Use of Methylphenidate or Amphetamines in Pregnancy.妊娠期使用哌醋甲酯或苯丙胺类药物与重大先天畸形风险的相关性。
J Clin Psychiatry. 2018 Jan/Feb;79(1). doi: 10.4088/JCP.18f12108.
5
Associations Between ADHD Medication Use in Pregnancy and Severe Malformations Based on Prenatal and Postnatal Diagnoses: A Danish Registry-Based Study.基于产前和产后诊断的妊娠期 ADHD 药物使用与严重畸形的相关性：一项丹麦基于登记的研究。
J Clin Psychiatry. 2021 Jan 5;82(1):20m13458. doi: 10.4088/JCP.20m13458.
6
Methylphenidate in Pregnancy: A Multicenter, Prospective, Comparative, Observational Study.孕期使用哌甲酯：一项多中心、前瞻性、对比性观察研究。
J Clin Psychiatry. 2016 Sep;77(9):1176-1181. doi: 10.4088/JCP.15m10083.
7
Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.妊娠期使用哌醋甲酯和苯丙胺与先天性畸形风险的关联：来自国际妊娠安全研究联盟的队列研究。
JAMA Psychiatry. 2018 Feb 1;75(2):167-175. doi: 10.1001/jamapsychiatry.2017.3644.
8
Fetal safety of methylphenidate-A scoping review and meta analysis.哌醋甲酯的胎儿安全性：范围综述和荟萃分析。
Reprod Toxicol. 2020 Apr;93:230-234. doi: 10.1016/j.reprotox.2020.03.003. Epub 2020 Mar 10.
9
First trimester in utero exposure to methylphenidate.胎儿在子宫内第一孕期接触哌醋甲酯。
Basic Clin Pharmacol Toxicol. 2013 Feb;112(2):73-6. doi: 10.1111/bcpt.12034.
10
Exposure to antazoline-naphazoline eye drops during pregnancy and the risk of congenital malformations: a Danish nationwide cohort study.妊娠期接触安特酰胺-萘甲唑啉滴眼液与先天性畸形风险：一项丹麦全国队列研究。
Acta Ophthalmol. 2019 Aug;97(5):505-509. doi: 10.1111/aos.13980. Epub 2018 Nov 26.
引用本文的文献
1
In utero exposure to methylphenidate, amphetamines and atomoxetine and offspring neurodevelopmental disorders - a population-based cohort study and meta-analysis.子宫内暴露于哌甲酯、苯丙胺和托莫西汀与后代神经发育障碍——一项基于人群的队列研究和荟萃分析。
Mol Psychiatry. 2025 Mar 27. doi: 10.1038/s41380-025-02968-4.
2
Methylphenidate and Atomoxetine in Pregnancy and Possible Adverse Fetal Outcomes: A Systematic Review and Meta-Analysis.哌醋甲酯和托莫西汀在妊娠中的应用及可能的胎儿不良结局：一项系统评价和荟萃分析。
JAMA Netw Open. 2024 Nov 4;7(11):e2443648. doi: 10.1001/jamanetworkopen.2024.43648.
3
A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia.特发性嗜睡症的药理学和非药理学干预措施的证据范围综述。
J Clin Sleep Med. 2024 Oct 1;20(10):1685-1704. doi: 10.5664/jcsm.11250.
4
Tackling obstructive sleep apnea with pharmacotherapeutics: expert guidance.药物治疗阻塞性睡眠呼吸暂停：专家指南
Expert Opin Pharmacother. 2024 Jun;25(8):1019-1026. doi: 10.1080/14656566.2024.2365329. Epub 2024 Jun 24.
5
Valproate Use During Spermatogenesis and Risk to Offspring.在精子发生过程中使用丙戊酸盐和对子代的风险。
JAMA Netw Open. 2024 Jun 3;7(6):e2414709. doi: 10.1001/jamanetworkopen.2024.14709.
6
In utero exposure to ADHD medication and long-term offspring outcomes.子宫内暴露于 ADHD 药物与长期后代结局。
Mol Psychiatry. 2023 Apr;28(4):1739-1746. doi: 10.1038/s41380-023-01992-6. Epub 2023 Feb 9.
7
Adverse Birth and Child Outcomes in Children Fathered by Men Treated with Antidiabetics Prior to Conception: A Nationwide Cohort Study.受孕前接受抗糖尿病药物治疗的男性所育子女的不良出生和儿童结局：一项全国性队列研究。
J Clin Med. 2022 Nov 7;11(21):6595. doi: 10.3390/jcm11216595.
8
Sleep disorders in pregnancy.孕期睡眠障碍
Breathe (Sheff). 2022 Jun;18(2):220004. doi: 10.1183/20734735.0004-2022. Epub 2022 Jun 7.
9
Armodafinil to reduce the sleepiness related side-effects of sleep restriction therapy being used to treat insomnia disorder: An open label clinical trial pilot study compared with historical controls.阿莫达非尼减少睡眠限制疗法治疗失眠障碍相关副作用的嗜睡：一项开放标签临床试验初步研究与历史对照比较。
J Sleep Res. 2023 Feb;32(1):e13699. doi: 10.1111/jsr.13699. Epub 2022 Aug 24.
10
A Novel and Selective Dopamine Transporter Inhibitor, -MK-26, Promotes Hippocampal Synaptic Plasticity and Restores Effort-Related Motivational Dysfunctions.一种新型、选择性的多巴胺转运体抑制剂 -MK-26，可促进海马突触可塑性，并恢复与努力相关的动机功能障碍。
Biomolecules. 2022 Jun 24;12(7):881. doi: 10.3390/biom12070881.
本文引用的文献
1
Association Between Methylphenidate and Amphetamine Use in Pregnancy and Risk of Congenital Malformations: A Cohort Study From the International Pregnancy Safety Study Consortium.妊娠期使用哌醋甲酯和苯丙胺与先天性畸形风险的关联：来自国际妊娠安全研究联盟的队列研究。
JAMA Psychiatry. 2018 Feb 1;75(2):167-175. doi: 10.1001/jamapsychiatry.2017.3644.
2
Narcolepsy with cataplexy and pregnancy: a case-control study.猝倒性睡眠发作伴发的发作性睡病与妊娠：病例对照研究。
J Sleep Res. 2018 Apr;27(2):268-272. doi: 10.1111/jsr.12567. Epub 2017 Jun 1.
3
Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies.发作性睡病与妊娠：249 例妊娠的回顾性欧洲评估。
J Sleep Res. 2013 Oct;22(5):496-512. doi: 10.1111/jsr.12047. Epub 2013 Apr 8.
4
Assessment of pregnancy outcomes in Czech and Slovak women with narcolepsy.捷克和斯洛伐克嗜睡症女性妊娠结局评估。
Med Sci Monit. 2010 Dec;16(12):SR35-40.
Zotero 插件